BioMarin BMRN0.75%increase; green up pointing triangle Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics FOLD-0.07%decrease; red down pointing triangle for about $4.8 billion ...

Fortress Biotech ( (FBIO)) has provided an announcement. On December 15, 2025, Fortress Biotech announced that the U.S. FDA accepted the resubmission of the New Drug Application for CUTX-101 as a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is part of a new ...

The Metro Tunnel Project features Alstom’s CBTC technology in combination with traditional signalling systems and includes five newly opened stations. Credit: Alstom SA. Alstom has delivered its ...

French biotech company Abivax SA started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for ...

Have you ever spent hours crafting a timeline chart, only to abandon it because it was too clunky, rigid, or just plain uninspiring? You’re not alone. Many tools promise sleek visuals but fall short ...

An illustration Anthropic commissioned to mark the release of Opus 4.5. (Anthropic) Hot on the heels of Google's Gemini 3 Pro release, Anthropic has announced an update for its flagship Opus model.

The Lions will be without one of their top offensive weapons as the NFL season hits the homestretch. On Friday, coach Dan Campbell told reporters that tight end Sam LaPorta had surgery on his back, ...

Borderlands 4 had one of 2025’s biggest releases in gaming, but it’s also struggling in some key ways that might doom the series’ future. Building off the success of the last 16 years of success in ...

A hot potato: Not everything that Sam Altman touches is as successful as ChatGPT. The OpenAI boss' crypto-based World project – formerly called Worldcoin – has an ambitious plan to scan a billion ...

The third-quarter 2025 reporting cycle of the Medical sector is currently approaching its end. The sector primarily comprises pharma/biotech and medical device companies. The Earnings Trends report ...

Rarely has a month gone by in 2025 without OpenAI signing another multibillion-dollar data center deal. In a lengthy post on X on Thursday, OpenAI CEO Sam Altman publicly clarified the totals. “We ...